Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 905

1.

Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation.

Mayo SJ, Messner HA, Rourke SB, Howell D, Victor JC, Lipton JH, Kuruvilla J, Gutpa V, Kim DDH, Michelis FV, Metcalfe K.

Bone Marrow Transplant. 2019 Nov 19. doi: 10.1038/s41409-019-0746-3. [Epub ahead of print]

PMID:
31745248
2.

Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab.

Salas MQ, Alahmari A, Lipton JH.

Eur J Haematol. 2019 Nov 6. doi: 10.1111/ejh.13343. [Epub ahead of print]

PMID:
31693245
3.

Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study.

Shah NP, García-Gutiérrez V, Jiménez-Velasco A, Larson S, Saussele S, Rea D, Mahon FX, Levy MY, Gómez-Casares MT, Pane F, Nicolini FE, Mauro MJ, Sy O, Martin-Regueira P, Lipton JH.

Leuk Lymphoma. 2019 Oct 24:1-10. doi: 10.1080/10428194.2019.1675879. [Epub ahead of print]

PMID:
31647335
4.

Mechanically strong and electrically conductive multilayer MXene nanocomposites.

Lipton J, Weng GM, Alhabeb M, Maleski K, Antonio F, Kong J, Gogotsi Y, Taylor AD.

Nanoscale. 2019 Nov 14;11(42):20295-20300. doi: 10.1039/c9nr06015d. Epub 2019 Oct 21.

PMID:
31633712
5.

My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults.

Alblooshi RM, Deotare U, Michelis FV, Thyagu S, Kim DDH, Lipton JH, ElGohary GM, Viswabandya A.

Bone Marrow Transplant. 2019 Oct 14. doi: 10.1038/s41409-019-0711-1. [Epub ahead of print] Review.

PMID:
31611631
6.

The role of ponatinib in chronic myeloid leukemia in the era of treatment free remission.

Andrews C, Lipton J.

Leuk Lymphoma. 2019 Sep 26:1-3. doi: 10.1080/10428194.2019.1665667. [Epub ahead of print] No abstract available.

PMID:
31556337
7.

Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation.

Salas MQ, Atenafu EG, Bautista MR, Prem S, Lam W, Datt Law A, Shaibani ZA, Kim DDH, Michelis FV, Lipton JH, Viswabandya A, Mattsson J, Kumar R.

Eur J Haematol. 2019 Sep 23. doi: 10.1111/ejh.13332. [Epub ahead of print]

PMID:
31549435
8.

Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosis.

Salas MQ, Lam W, Law AD, Kim DDH, Michelis FV, Loach D, Al-Shaibani Z, Lipton JH, Kumar R, Mattsson J, Viswabandya A.

Eur J Haematol. 2019 Dec;103(6):597-606. doi: 10.1111/ejh.13327. Epub 2019 Sep 30.

PMID:
31514253
9.

Tyrosine Kinase Inhibitors in the Clinical Setting: A Conundrum of Choices.

Bankar A, Lipton JH.

Acta Haematol. 2019 Sep 12:1-3. doi: 10.1159/000502472. [Epub ahead of print] No abstract available.

10.

Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia.

Salas MQ, Prem S, Atenafu EG, Law AD, Lam W, Al-Shaibani Z, Loach D, Kim DDH, Michelis FV, Lipton JH, Kumar R, Mattsson J, Viswabandya A.

Eur J Haematol. 2019 Nov;103(5):510-518. doi: 10.1111/ejh.13321. Epub 2019 Sep 9.

PMID:
31449699
11.

Orexinergic modulation of serotonin neurons in the dorsal raphe of a diurnal rodent, Arvicanthis niloticus.

Adidharma W, Deats SP, Ikeno T, Lipton JW, Lonstein JS, Yan L.

Horm Behav. 2019 Nov;116:104584. doi: 10.1016/j.yhbeh.2019.104584. Epub 2019 Aug 31.

PMID:
31445011
12.

Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment.

Prem S, Atenafu EG, Avena J, Bautista R, Law A, Lam W, Michelis FV, Kim DDH, Viswabandya A, Lipton JH, Mattsson J, Kumar R.

Eur J Haematol. 2019 Nov;103(5):483-490. doi: 10.1111/ejh.13314. Epub 2019 Sep 5.

PMID:
31418930
13.

Epstein-Barr virus associated post-transplant lymphoproliferative disorder mimicking acute graft versus host disease.

Prem S, Al-Shaibani Z, Michelis FV, Kim D, Viswabandya A, Lipton JH, Kumar R, Mattsson J, Law A, Lam W.

Eur J Haematol. 2019 Nov;103(5):519-522. doi: 10.1111/ejh.13309. Epub 2019 Aug 27.

PMID:
31389104
14.

A Promising Carbon/g-C3 N4 Composite Negative Electrode for a Long-Life Sodium-Ion Battery.

Weng GM, Xie Y, Wang H, Karpovich C, Lipton J, Zhu J, Kong J, Pfefferle LD, Taylor AD.

Angew Chem Int Ed Engl. 2019 Sep 23;58(39):13727-13733. doi: 10.1002/anie.201905803. Epub 2019 Aug 14.

PMID:
31298771
15.

Yet do much less...so much less!

Lipton JH.

Blood. 2019 Jul 4;134(1):6-7. doi: 10.1182/blood.2019001014. No abstract available.

PMID:
31273004
16.

The true value of second-generation TKIs as first-line therapy in chronic myeloid leukaemia.

Andrews CN, Lipton J.

Lancet Haematol. 2019 Aug;6(8):e385-e386. doi: 10.1016/S2352-3026(19)30112-7. Epub 2019 Jun 14. No abstract available.

PMID:
31208942
17.

Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease.

Shapiro RM, Shin E, Law AD, Lam W, Michelis FV, Viswabandya A, Kumar R, Lipton JH, Messner H, Mattsson J, Kim DDH.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1761-1769. doi: 10.1016/j.bbmt.2019.05.029. Epub 2019 Jun 4.

PMID:
31170520
18.

Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia.

Hirt C, Iannazzo S, Chiroli S, McGarry LJ, le Coutre P, Stenke L, Dahlén T, Lipton JH.

Appl Health Econ Health Policy. 2019 Aug;17(4):555-567. doi: 10.1007/s40258-019-00489-0.

PMID:
31168745
19.

Simprovisation: A model for student-led simulation.

Babla K, Lipton J, Williams S, Chopra P, Thenabadu S.

Clin Teach. 2019 Apr 22. doi: 10.1111/tct.13021. [Epub ahead of print]

PMID:
31012260
20.

Patients' perspectives on the definition of cure in chronic myeloid leukemia.

Flynn KE, Mauro MJ, George G, Hinman A, Baim A, Kota V, Larson RA, Lipton JH, Thompson JE, Wadleigh M, Atallah E.

Leuk Res. 2019 May;80:40-42. doi: 10.1016/j.leukres.2019.03.007. Epub 2019 Mar 28. No abstract available.

PMID:
30955853

Supplemental Content

Loading ...
Support Center